Page last updated: 2024-10-19

2,3,4,5-tetrahydroxypentanal and Cardiomyopathies

2,3,4,5-tetrahydroxypentanal has been researched along with Cardiomyopathies in 2 studies

Cardiomyopathies: A group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classified according to their predominant pathophysiological features (DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY) or their etiological/pathological factors (CARDIOMYOPATHY, ALCOHOLIC; ENDOCARDIAL FIBROELASTOSIS).

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Xu, GR1
Zhang, C1
Yang, HX1
Sun, JH1
Zhang, Y1
Yao, TT1
Li, Y1
Ruan, L1
An, R1
Li, AY1
Nguyen, MN1
Su, Y1
Kiriazis, H1
Yang, Y1
Gao, XM1
McMullen, JR1
Dart, AM1
Du, XJ1

Other Studies

2 other studies available for 2,3,4,5-tetrahydroxypentanal and Cardiomyopathies

ArticleYear
Modified citrus pectin ameliorates myocardial fibrosis and inflammation via suppressing galectin-3 and TLR4/MyD88/NF-κB signaling pathway.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2020, Volume: 126

    Topics: Animals; Biomarkers; Biopsy; Cardiomyopathies; Cytokines; Disease Susceptibility; Echocardiography;

2020
Upregulated galectin-3 is not a critical disease mediator of cardiomyopathy induced by β
    American journal of physiology. Heart and circulatory physiology, 2018, 06-01, Volume: 314, Issue:6

    Topics: Amino Sugars; Animals; Cardiomyopathies; Disease Models, Animal; Fibrosis; Galectin 3; Genetic Predi

2018